Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Recurrent infections and Decreased total neutrophil count. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Recurrent infections, Decreased total neutrophil count |
CSF3R encodes colony stimulating factor 3 receptor (836 aa). Receptor for granulocyte colony-stimulating factor (CSF3), essential for granulocytic maturation. Highest expression in Whole Blood (2,126 TPM) and Spleen (383.0 TPM).
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency is associated with mutations in the CSF3R gene on chromosome 1.
CSF3R is classified as a druggable target (Clinically Actionable, Druggable Genome, and External Side Of Plasma Membrane categories) with score 3.9.
Genetic testing for CSF3R is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autosomal recessive severe congenital neutropenia due to CSF3R deficiency.
12 publications have been identified in PubMed for autosomal recessive severe congenital neutropenia due to CSF3R deficiency. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 33% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 4:07 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Bone marrow maturation arrest |
Laboratory research |
3 |
25% |
Research summaries | 2 | 17% |
Disease patterns and progression | 2 | 17% |
New treatment approaches | 1 | 8% |
Pantea CL (2026). [PMID: 41751872](https://pubmed.ncbi.nlm.nih.gov/41751872/). *International journal of molecular sciences*. [Case Report / Case Series]
Miyamoto R (2026). [PMID: 41485978](https://pubmed.ncbi.nlm.nih.gov/41485978/). *The Journal of veterinary medical science*. [Case Report / Case Series]
Sun Y (2026). [PMID: 41560087](https://pubmed.ncbi.nlm.nih.gov/41560087/). *Medicine*. [Case Report / Case Series]
Fekadu-Siebald J (2025). [PMID: 39775668](https://pubmed.ncbi.nlm.nih.gov/39775668/). *Blood advances*. [Case Report / Case Series]
Kızılay DÖ (2025). [PMID: 39980410](https://pubmed.ncbi.nlm.nih.gov/39980410/). *Pediatric blood & cancer*. [Basic Science / Preclinical]
Meng X (2024). [PMID: 38286463](https://pubmed.ncbi.nlm.nih.gov/38286463/). *Blood advances*. [Gene Therapy / Novel Therapeutics]
Ritter MU (2024). [PMID: 39436283](https://pubmed.ncbi.nlm.nih.gov/39436283/). *The CRISPR journal*. [Epidemiology / Natural History]
Katsaras G (2024). [PMID: 38921186](https://pubmed.ncbi.nlm.nih.gov/38921186/). *Hematology reports*. [Review / Meta-Analysis]
Bao K (2024). [PMID: 39096313](https://pubmed.ncbi.nlm.nih.gov/39096313/). *Proteomics. Clinical applications*. [Epidemiology / Natural History]
Parisi X (2024). [PMID: 38589208](https://pubmed.ncbi.nlm.nih.gov/38589208/). *Journal of clinical pathology*. [Basic Science / Preclinical]